Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3746
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDale, R.en
dc.contributor.authorMerheb, V.en
dc.contributor.authorNosadini, M.en
dc.contributor.authorFung, V.en
dc.contributor.authorBrilot, F.en
dc.contributor.authorRamanathan, S.en
dc.contributor.authorPrelog, K.en
dc.contributor.authorBarnes, E.en
dc.contributor.authorTantsis, E.en
dc.contributor.authorReddel, S.en
dc.contributor.authorHenderson, A.en
dc.contributor.authorVucic, O.en
dc.contributor.authorGorman, M.en
dc.contributor.authorBenson, L.en
dc.contributor.authorAlper, G.en
dc.contributor.authorRiney, C.en
dc.contributor.authorBarnett, M.en
dc.contributor.authorParratt, J.en
dc.contributor.authorHardy, T.en
dc.contributor.authorLeventer, R.en
dc.date.accessioned2022-11-07T23:45:41Z-
dc.date.available2022-11-07T23:45:41Z-
dc.date.issued2016en
dc.identifier.citation86, (16), 2016en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/3746-
dc.description.abstractObjective: We performed clinical and radiological characterisation of first episode optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated ON(MOG-ON), aquaporin-4 antibody-associated ON(AQP4-ON), and multiple sclerosis(MS-ON). We hypothesised there would be specific radiological predictors depending on the cause of ON. Background: Early recognition of the etiology of ON affects treatment decisions and prognosis. Design/Methods: We performed a flow cytometry cell-based assay using live HEK293 cells expressing full-length human MOG to test the serum of 23 adults with AQP4 antibody-negative neuromyelitis optica spectrum disorders. Blinded neuroradiological assessment was subsequently performed on magnetic resonance imaging of fifty patients (mean age 24 years, range 3-58, 41 females) with a first episode of ON, including MOG-ON (n=19), AQP4-ON (n=11), MS-ON (n=13), and unclassified ON (n=7). Results: MOG antibodies were detected in 9/23 patients, all of whom had bilateral ON. MOG-ON patients were more likely to have a relapsing course and be steroid responsive. Bilateral involvement was more common in MOG-ON and AQP4-ON than MS-ON (84[percnt] v.82[percnt] v.23[percnt]), optic nerve head swelling was more common in MOG-ON (53[percnt] v.9[percnt] v.0[percnt]), chiasmal involvement was more common in AQP4-ON (5[percnt] v.64[percnt] v.15[percnt]), and bilateral optic tract involvement was more common in AQP4-ON (0[percnt] v.45[percnt] v.0[percnt]). Retrobulbar optic nerve involvement was more common in MOG-ON, whereas intracranial optic nerve involvement was more common in AQP4-ON. MOG-ON and AQP4-ON had longer lesion lengths and lesion extent scores than MS-ON. AQP4-ON more frequently had severe and sustained visual impairment. Conclusions: MOG antibodies are associated with a bilateral ON phenotype and are steroid responsive. MOG and AQP4-ON are frequently bilateral and longitudinally extensive, compared with MS-ON. MOG-ON tends to involve the anterior optic pathway whereas AQP4-ON tends to involve the posterior optic pathway. These radiological predictors may expedite diagnosis at the first presentation of ON, with therapeutic and prognostic implications.L722502922016-04-27 <br />en
dc.language.isoenen
dc.relation.ispartofNeurologyen
dc.titleMyelin oligodendrocyte glycoprotein antibodies are associated with bilateral and recurrent optic neuritis and have a distinct radiological profile to multiple sclerosis or aquaporin-4 antibody-associated optic neuritisen
dc.typeArticleen
dc.subject.keywordsetiologyen
dc.subject.keywordsantibodymyelin oligodendrocyte glycoproteinen
dc.subject.keywordsaquaporin 4 antibodyen
dc.subject.keywordssteroiden
dc.subject.keywordsnitrogen 13en
dc.subject.keywordsoptic neuritisen
dc.subject.keywordsAmericanen
dc.subject.keywordsmultiple sclerosisen
dc.subject.keywordsneurologyen
dc.subject.keywordshumanen
dc.subject.keywordspatienten
dc.subject.keywordsoptic nerveen
dc.subject.keywordsvisual systemen
dc.subject.keywordsmyelooptic neuropathyen
dc.subject.keywordsadulten
dc.subject.keywordsserumen
dc.subject.keywordsassayen
dc.subject.keywordsdiagnosisen
dc.subject.keywordsphenotypeen
dc.subject.keywordsflow cytometryen
dc.subject.keywordsprognosisen
dc.subject.keywordsoptic tracten
dc.subject.keywordsswellingen
dc.subject.keywordsnuclear magnetic resonance imagingen
dc.subject.keywordsretrobulbar drug administrationen
dc.subject.keywordsvisual impairmenten
dc.subject.keywordsdiseasesen
dc.subject.keywordsfemaleen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L72250292&from=exporten
dc.identifier.risid2225en
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

26
checked on Apr 29, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.